ofloxacin has been researched along with Pulmonary Consumption in 116 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (9.48) | 18.7374 |
1990's | 36 (31.03) | 18.2507 |
2000's | 40 (34.48) | 29.6817 |
2010's | 29 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Achar, V; Arora, U; Awasthy, D; Bharath, S; Bheemarao, U; Chinnapattu, M; Coulson, M; de Sousa, SM; Ganguly, S; Gaonkar, S; Ghosh, A; Hameed P, S; Hoffner, S; Humnabadkar, V; Kaur, P; Kumar K N, M; Kumar, CN; Madhavapeddi, P; Manjrekar, P; Menasinakai, S; Mukherjee, K; Nandishaiah, R; Narayan, C; Panduga, V; Patil, V; Puttur, J; Raichurkar, A; Ramya, VK; Reddy, J; Rudrapatana, S; Sambandamurthy, VK; Shanbhag, G; Sharma, S; Sharma, U; Shinde, V; Solapure, S; Waterson, D; Werngren, J | 1 |
Bablishvili, N; Blumberg, HM; Gandhi, NR; Kempker, RR; Mathema, B; Shashkina, E; Tukvadze, N | 1 |
Audagnotto, S; Calleris, G; Cardellino, C; Corcione, S; De Rosa, FG; Frea, B; Gontero, P; Marra, G; Oderda, M | 1 |
Chandran, A; Dixit, R; Gupta, N; Kala, DK; Patni, T; Sharma, AK; Verma, S | 1 |
Ahmed, S; Al-Shaer, MH; Alghamdi, WA; Alkabab, Y; Alsultan, A; An, G; Banu, S; Barbakadze, K; Cegielski, JP; Heysell, SK; Houpt, E; Kempker, RR; Kipiani, M; Mikiashvili, L; Peloquin, CA | 1 |
Chernyaeva, E; Fedorova, E; Korneev, Y; Kozlov, A; Zhemkova, G | 1 |
Ahmed, I; Hasan, R; Inayat, R; Jabeen, K | 1 |
Davis, JG; Farley, J; Lancaster, J; Odendaal, R; Shean, K; Van der Walt, M | 1 |
Davies, GR; Titarenko, AF; Ziganshina, LE | 1 |
Gratz, J; Heysell, SK; Houpt, ER; Kibiki, GS; Kumburu, H; Mpagama, SG; Ndusilo, N; Peloquin, CA; Stroup, S | 1 |
Kalmataeva, Z; Kurakpaev, K; Maimakov, T; Sadykova, L; Šmigelskas, K | 1 |
Ajbani, K; Catanzaro, A; Caviedes, L; Coronel, J; Crudu, V; Desmond, E; Eisenach, K; Ganiats, TG; Garfein, RS; Groessl, EJ; Jackson, RL; Klages, S; Moore, D; Rodrigues, C; Rodwell, TC; Romancenco, E; Trollip, AP; Victor, T; Vineet, VP | 1 |
Apsindzelashvili, R; Bablishvili, N; Blumberg, HM; Kempker, RR; Tukvadze, N | 1 |
Cesur, S; Şimşek, H; Tarhan, G | 1 |
Lee, CH; Lee, LN; Lee, MC; Wang, JT; Wang, JY; Yu, MC | 1 |
Javed, I; Khaliq, T; Mahmood, Z; Shahid, M | 1 |
Forsman, LD; Hoffner, S; Hu, Y; Mansjö, M; Werngren, J; Xu, B; Zheng, R; Zheng, X | 1 |
Chaiprasert, A; Disratthakit, A; Doi, N; Leechawengwongs, M; Prammananan, T; Thaipisuttikul, I; Tribuddharat, C | 1 |
Chen, S; Dong, L; Huang, H; Köser, CU; Moradigaravand, D; Parkhill, J; Peacock, SJ; Schön, T; Shang, Y; Wang, G; Wei, G; Yu, X | 1 |
Afridi, MZ; Agha, N; Ahmad, N; Akhtar, S; Ansarie, M; Awan, SR; Chaudry, MA; Chima, MK; Choudry, K; Ghafoor, A; Hasan, R; Iqbal, ZH; Javaid, A; Khan, AR; Khan, S; Qadeer, E; Qayyum, S; Rizvi, N; Shaheen, Z; Zafar, A | 1 |
Kirtaeva, OV; Lazareva, IaV; Sokolova, GB; Tsybanev, AA | 1 |
Kunichan, AD; Lazareva, IaV; Sokolova, GB | 1 |
Chen, XC; Gou, JZ; Li, MZ; Peng, YZ; Tang, ZJ; Tong, XD; Yue, XH; Zhou, BP | 1 |
Amiri, M; Baghaei, P; Caminero, JA; Chitsaz, E; Farnia, P; Kazempour, M; Mansouri, D; Marjani, M; Masjedi, MR; Shamaei, M; Tabarsi, P; Velayati, AA | 1 |
Yin, X; Yu, Z | 1 |
Hagiwara, E; Komatsu, S; Ogura, T; Sawahata, M; Sekine, A; Takahashi, H; Tsuchiya, N | 1 |
Chang, KC; Leung, CC; Tam, CM; Yew, WW | 1 |
Akagawa, S; Ariga, H; Kaneko, Y; Kawabe, Y; Kawashima, M; Kunogi, M; Machida, K; Masuda, K; Matsui, H; Matsui, Y; Nagai, H; Nagayama, N; Nakajima, Y; Ohshima, N; Shimada, M; Suzuki, J; Tamura, A; Toyota, E | 1 |
Eisenberg, N; Govender, K; Hartman, TE; Hatfull, GF; Jacobs, WR; Jain, P; Kriakov, J; Larsen, MH; Makume, M; Moodley, P; O'Donnell, MR; Sturm, AW; Thaler, DS | 1 |
Kato, S; Kobashi, Y; Mouri, K; Obase, Y; Oka, M | 1 |
Bukatina, AA; Galkina, KY; Isaeva, YD; Makarova, MV; Moroz, AM; Nosova, EY | 1 |
Banavaliker, JN; Behera, D; Bhatnagar, AK; Hanif, M; Kaushik, A; Makkar, N; Pande, JN; Porwal, C; Singh, UB; Singla, R | 1 |
Covi, M; Fabbri, LM; Ferrara, G; Franco, F; Meschiari, E; Richeldi, L; Vailati, P; Velluti, G | 1 |
Istomin, EA; Mokrousov, IV; Narvskaia, OV; Otten, TF; Vishnevskiĭ, BI | 1 |
Maroto Arce, N; Ponce, M | 1 |
Chau, CH; Lee, J; Yew, WW | 1 |
Chen, L; Chen, QL; Yin, JJ | 1 |
Mishin, VIu; Vasil'eva, IA | 1 |
Gao, WW; Huang, XR; Ma, Y; Pan, YX; Wang, SM; Zhang, XX | 1 |
Han, L; Lee, DH; Lee, WC; Mitnick, CD; Park, SK; Seung, KJ | 1 |
Li, SM; Xing, BC; Zheng, XM | 1 |
Kam, KM; Yip, CW | 1 |
Desmond, EP; Nieda, RR; Sanders, CA | 1 |
Li, JH; Wang, YZ; Zhang, HJ | 1 |
Andrianasolo, D; Ramarokoto, H; Ramaroson, F; Rasolofo Razanamparany, V; Rasolonavalona, T; Ratsimba, L; Razafitsiarovana, I; Vincent, V | 1 |
Bose, M; Dam, T; Isa, M | 1 |
Bjune, G; Caugant, DA; Mariandyshev, AO; Sandven, P; Toungoussova, OS | 1 |
Martin, A; Palomino, JC; Portaels, F | 1 |
Squire, SB; Vizel, AA; Ziganshina, LE | 1 |
Branda, JA; Gibbons, FK; Shepard, JA | 1 |
Han, SK; Kang, CH; Kim, HJ; Kim, JH; Kim, YT; Kim, YW; Lee, CT; Lee, SM; Shim, YS; Sung, SW; Yim, JJ; Yoo, CG | 1 |
Boom, WH; Charlebois, ED; Daley, CL; Debanne, SM; Dietze, R; Eisenach, KD; Hadad, DJ; Jankus, DD; Johnson, JL; Maciel, E; Palaci, M; Peloquin, CA | 1 |
Bai, KJ; Chiang, CY; Enarson, DA; Hsu, CJ; Huang, RM; Lin, TP; Suo, J; Yu, MC | 1 |
Conde, MB; Dorman, SE; Guerra, RL; Mello, FC; Muzy-de-Souza, GR; Szklo, A | 1 |
Boom, WH; Dietze, R; Hadad, DJ; Johnson, JL; Molino, LP; Palaci, M; Peloquin, CA | 1 |
Squire, SB; Ziganshina, LE | 1 |
Grupper, M; Potasman, I | 1 |
Baba, T; Endo, T; Hagiwara, E; Komatsu, S; Matsumoto, Y; Nishihira, R; Ogura, T; Sato, T; Sekine, A; Shinohara, T; Sogo, Y; Takahashi, H | 1 |
Tsukamura, M; Yanase, M | 1 |
Bagnato, GF; Cucinotta, D; Di Cesare, E; Gulli, S | 1 |
Goya, T; Hamakubo, S; Hanaoka, T; Hosaka, K; Miya, T | 1 |
Mühlberger, F; Nasbimana, J; Nturanye, F; Portaels, F | 1 |
Berning, SE; Iseman, MD; Madsen, L; Peloquin, CA | 1 |
Cynamon, MH; Klemens, SP; Rogge, MC; Sharpe, CA | 1 |
Besson, M; Cambau, E; Grosset, J; Jarlier, V; Sougakoff, W; Truffot-Pernot, C | 1 |
Chau, CH; Lee, J; Wong, PC; Yew, WW | 1 |
Chan, CY; Cheng, AF; Cheung, SW; Wong, CF; Wong, PC; Yew, WW | 1 |
Sahoo, RC | 1 |
Chau, CH; Lee, J; Wong, CF; Wong, PC; Yew, WW | 1 |
Bhagat, R; Panchal, N; Shah, A | 1 |
Faravelli, B | 1 |
Chau, CH; Wen, KH; Yew, WW | 1 |
Tanaka, E | 1 |
Zalaudek, G | 1 |
Hirose, T; Ikeda, T; Iwanaga, T; Kishikawa, R; Nishima, S; Tsurutani, H; Yokota, K | 1 |
Higgins, K; Maxwell, R; Meador, J; Onorato, IM; Ridzon, R; Weismuller, P | 1 |
Kuś, J; Michałowska-Mitczuk, D | 1 |
Chirgwin, KD; Cohn, DL; el-Sadr, WM; Hafner, R; Heifets, L; Jones, BE; Klein, O; Matts, JP; Medard, F; Mildvan, D; Nelson, ET; Olibrice, M; Perlman, DC; Salomon, N; Telzak, EE | 1 |
Chau, CH; Yew, WW | 1 |
Pei, X; Yang, Y; Ye, Z | 1 |
Benson, CA; Chirgwin, KD; El-Sadr, WM; Matts, JP; Nelson, ET; Perlman, DC; Sepkowitz, KA; Telzak, EE | 1 |
Chen, M; Qian, H; Zhang, Y | 1 |
Maranetra, KN | 1 |
Hudoyo, A; Mangunnegoro, H | 1 |
Falquera Sacrest, M; Martín Marco, A; Rubio Cabàllero, M | 1 |
Chan, CK; Chau, CH; Lee, J; Leung, CC; Tam, CM; Wong, PC; Yew, WW | 1 |
Donald, PR; Githui, W; Kam, KM; Lam, CW; Mitchison, DA; Odhiambo, J; Paramasivan, CN; Sirgel, FA; Sole, KM; Tam, CM; Umapathy, KC | 1 |
KiaNoury, D; Timpone, J; Yeager, H | 1 |
Chierakul, N; Chindavijak, B; Chulavatnatol, S; Klomsawat, D | 1 |
Belen, VA; Cardaño, RC; Derilo, JO; Grimaldo, ER; Quelapio, MI; Rivera, AB; Tupasi, TE | 1 |
Ataç, G; Kapakli, N; Karasulu, L; Kir, A; Ozmen, I; Sevim, T; Tahaoğlu, K; Törün, T | 1 |
Agarwal, SR; Nandeesh, HP; Saigal, S; Sarin, SK | 1 |
Hoeppner, V; Marciniuk, D; Peloquin, CA; Reid, J | 1 |
Harada, H; Iwasaki, Y; Minagawa, T; Nagata, K; Nakagawa, M; Nakanishi, M; Natsuhara, A; Takemura, Y | 1 |
Ashkin, D; Berning, SE; Bulpitt, AE; Hollender, ES; Narita, M; Peloquin, CA; Stambaugh, JJ | 1 |
Gałazka, J; Zwoliński, J | 1 |
Kwan, SY; Lee, J; Wong, PC; Yew, WW | 2 |
Eirei, J; Kawahara, S | 1 |
Hara, K; Kaku, M; Koga, H; Kohno, S; Maesaki, S | 1 |
Galenko, NN; Koriakin, VA; Zeliger, LR | 1 |
Ikeda, N; Inoue, S; Kita, N; Matsumoto, T; Nakae, I; Nakatani, K; Ozawa, S; Sakatani, M; Takahasi, K; Tanaka, S | 1 |
Chau, PY; Khin, MA; Kwan, SY; Ma, WK; Yew, WW | 1 |
Krakówka, P; Krasucka-Kluźniak, A | 1 |
Chen, CH; Heifets, LB; Lindholm-Levy, PJ; Shih, JF | 1 |
Ikeda, N; Iwagaki, K; Kanai, K; Kanetsuna, F; Kita, N; Matsumoto, T; Sirai, F; Takenaka, K; Ueda, E; Yamazaki, M | 1 |
Arai, R; Furuse, K; Kawahara, M; Kita, N; Sakatani, M | 1 |
Saito, H; Tsukamura, M; Yasuda, Y; Yoshii, S | 1 |
Cassier, C; Koch, G; Schmücker, P | 1 |
Amano, H; Miyachi, T; Nakamura, E; Tsukamura, M; Tsunekawa, H | 1 |
Amano, H; Nakamura, E; Tsukamura, M; Yanase, M; Yasuda, Y; Yoshii, S | 1 |
Kita, N; Mitani, Y; Shimoide, H; Tsukamura, M; Wada, T; Yoshimoto, K | 1 |
6 review(s) available for ofloxacin and Pulmonary Consumption
Article | Year |
---|---|
Fluoroquinolones for treating tuberculosis (presumed drug-sensitive).
Topics: Antitubercular Agents; Ciprofloxacin; Drug Substitution; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Randomized Controlled Trials as Topic; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
[Pulmonary mycobacteriosis caused by Mycobacterium peregrinum in a young, healthy man].
Topics: Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Levofloxacin; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2010 |
[Tuberculosis and the digestive tract].
Topics: Adenosine Deaminase; Antitubercular Agents; Ascitic Fluid; Biomarkers; CA-125 Antigen; Chemical and Drug Induced Liver Injury; Diagnostic Imaging; Drug Therapy, Combination; Humans; Intestinal Obstruction; Laparoscopy; Ofloxacin; Peritonitis, Tuberculous; Radiography; Risk Factors; Tuberculin Test; Tuberculosis, Gastrointestinal; Tuberculosis, Pulmonary | 2003 |
Fluoroquinolones for treating tuberculosis.
Topics: Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Randomized Controlled Trials as Topic; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2005 |
Fluoroquinolones for treating tuberculosis.
Topics: Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Randomized Controlled Trials as Topic; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2008 |
Minimal inhibitory concentrations of rifabutin, ciprofloxacin, and ofloxacin against Mycobacterium tuberculosis isolated before treatment of patients in Taiwan.
Topics: Antitubercular Agents; Ciprofloxacin; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; Mycobacterium tuberculosis; Ofloxacin; Rifabutin; Rifamycins; Taiwan; Tuberculosis, Pulmonary; United States | 1989 |
18 trial(s) available for ofloxacin and Pulmonary Consumption
Article | Year |
---|---|
[Floracide, a Russian 3rd generation fluoroquinolone in complex therapy of tuberculosis].
Topics: Adult; Antitubercular Agents; Arthralgia; Diarrhea; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fever; Fluoroquinolones; Hepatitis; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Nausea; Ofloxacin; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2008 |
[Levofloxacin (Tavanic) in complex therapy of tuberculosis].
Topics: Adult; Animals; Antitubercular Agents; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Levofloxacin; Lung; Male; Mice; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Radiography; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2009 |
[Efficacy of ofloxacin (zanocin) in the treatment of multidrug resistant pulmonary tuberculosis].
Topics: Administration, Oral; Adult; Anti-Infective Agents; Antitubercular Agents; Diarrhea; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Exanthema; Humans; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Pneumothorax, Artificial; Treatment Outcome; Tuberculosis, Pulmonary | 2003 |
[Short-term effect of treatment protocol utilizing levofloxacin, pasiniazide and M. Vaccae on multi- drug resistant pulmonary tuberculosis].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aminosalicylic Acid; Aminosalicylic Acids; Clinical Protocols; Drug Therapy, Combination; Female; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Ofloxacin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Single-Blind Method; Tuberculosis, Pulmonary | 2006 |
Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Brazil; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Quinolines; Tuberculosis, Pulmonary | 2008 |
[Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Kanamycin; Mycobacterium avium-intracellulare Infection; Ofloxacin; Pilot Projects; Rifampin; Tuberculosis, Pulmonary | 1996 |
Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Tr
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Recurrence; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
[Analysis of causes of drug resistance and therapeutic effects on 27 multi-drug resistant pulmonary tuberculosis patients].
Topics: Adult; Aminosalicylic Acid; Anti-Infective Agents; Antitubercular Agents; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kanamycin; Male; Middle Aged; Ofloxacin; Prothionamide; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
[Bronchofiberscope and catheter intervention in treatment of multi-drug resistant pulmonary tuberculosis].
Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bronchoscopy; Catheterization, Peripheral; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Ofloxacin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
Efficacy of low-dose ofloxacin in the treatment of multidrug-resistant tuberculosis in Indonesia.
Topics: Adolescent; Adult; Anti-Infective Agents; Female; Humans; Male; Middle Aged; Ofloxacin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1999 |
A multicentre study of the early bactericidal activity of anti-tuberculosis drugs.
Topics: Adult; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Hong Kong; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; South Africa; Sputum; Tuberculosis, Pulmonary | 2000 |
Safety of an ofloxacin-based antitubercular regimen for the treatment of tuberculosis in patients with underlying chronic liver disease: a preliminary report.
Topics: Adolescent; Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Ofloxacin; Peritonitis, Tuberculous; Risk Factors; Tuberculosis, Gastrointestinal; Tuberculosis, Pulmonary | 2001 |
A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service/British Medical Research Council.
Topics: Adult; Aged; Antitubercular Agents; Chronic Disease; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifabutin; Rifampin; Rifamycins; Sputum; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 1992 |
[Evaluation of new antitubercular agents--new quinolone agents].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Humans; Mycobacterium tuberculosis; Ofloxacin; Quinolones; Tuberculosis, Pulmonary | 1992 |
Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Prospective Studies; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1992 |
[Therapeutic effect of ofloxacin on intractable pulmonary tuberculosis and ofloxacin resistance of tubercle bacilli isolated from the patients. Chest DIsease Cooperative Study Unit of National Sanatoriums in Kinki District].
Topics: Adult; Aged; Aged, 80 and over; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Retrospective Studies; Tuberculosis, Pulmonary | 1991 |
[2 cases of drug-resistant pulmonary tuberculosis treated with ofloxacin].
Topics: Adult; Antitubercular Agents; Chronic Disease; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Pulmonary | 1989 |
92 other study(ies) available for ofloxacin and Pulmonary Consumption
Article | Year |
---|---|
Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.
Topics: Acute Disease; Administration, Oral; Animals; Antitubercular Agents; Bacterial Proteins; Biological Availability; Chronic Disease; DNA Gyrase; Drug Resistance, Bacterial; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Fluoroquinolones; Humans; Macrophages; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutation; Mycobacterium tuberculosis; Piperidines; Protein Subunits; Rats; Stereoisomerism; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tuberculosis, Pulmonary | 2014 |
Impact of
Topics: Acetyltransferases; Antitubercular Agents; Bacterial Proteins; Base Sequence; Capreomycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Georgia (Republic); Humans; Kanamycin; Mycobacterium tuberculosis; Ofloxacin; Retrospective Studies; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Miliary pulmonary infection after BCG intravesical instillation: a rare, misdiagnosed and mistreated complication.
Topics: Aged; Antitubercular Agents; BCG Vaccine; Bronchoalveolar Lavage Fluid; Carcinoma, Transitional Cell; Delayed Diagnosis; Fever of Unknown Origin; Humans; Immunotherapy; Male; Mycobacterium bovis; Ofloxacin; Sputum; Tuberculosis, Miliary; Tuberculosis, Pulmonary; Urinary Bladder Neoplasms | 2017 |
A study on pattern of resistance to second line anti tubercular drugs among multi drug resistant tuberculosis patients.
Topics: Aminoglycosides; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; India; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Prevalence; Tuberculosis, Pulmonary | 2018 |
Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Moxifloxacin; Ofloxacin; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2019 |
Characterization of multiple and extensively drug resistant Mycobacterium tuberculosis isolates with different ofloxacin-resistance levels.
Topics: Amino Acid Substitution; Antitubercular Agents; DNA Gyrase; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Genetic Variation; Genotype; Humans; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Oligonucleotide Array Sequence Analysis; Tuberculosis, Pulmonary | 2013 |
Susceptibility testing of extensively drug-resistant and pre-extensively drug-resistant Mycobacterium tuberculosis against levofloxacin, linezolid, and amoxicillin-clavulanate.
Topics: Acetamides; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Pakistan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
Serious treatment related adverse drug reactions amongst anti-retroviral naïve MDR-TB patients.
Topics: Adult; Antitubercular Agents; Coinfection; Cycloserine; Drug Resistance, Multiple, Bacterial; Female; Hearing Loss; HIV Infections; Humans; Isoxazoles; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Prospective Studies; Psychoses, Substance-Induced; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis.
Topics: Adolescent; Adult; Amikacin; Antitubercular Agents; Cycloserine; Ethionamide; Female; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Sputum; Tanzania; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
Treatment of tuberculosis in South Kazakhstan: clinical and economical aspects.
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Capreomycin; Cycloserine; Drug Costs; Female; Humans; Kazakhstan; Male; Middle Aged; Ofloxacin; Prothionamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; India; Kanamycin; Microbial Sensitivity Tests; Microscopy; Moldova; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Peru; Predictive Value of Tests; Reproducibility of Results; South Africa; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
Performance of the MTBDRsl assay in Georgia.
Topics: Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Feasibility Studies; Georgia (Republic); Humans; Kanamycin; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Ofloxacin; Predictive Value of Tests; Reproducibility of Results; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Workflow | 2014 |
[Evaluation of second-line antituberculosis drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis complex isolates by E-test method].
Topics: Acetamides; Antitubercular Agents; Culture Media; Drug Resistance, Multiple, Bacterial; Ethionamide; Humans; Kanamycin; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Reagent Strips; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2015 |
Fluoroquinolone use delays tuberculosis treatment despite immediate mycobacteriology study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; Female; Fluoroquinolones; Follow-Up Studies; Humans; Levofloxacin; Linear Models; Longitudinal Studies; Male; Middle Aged; Moxifloxacin; Multivariate Analysis; Mycobacterium tuberculosis; Ofloxacin; Pneumonia, Bacterial; Taiwan; Tuberculosis, Pulmonary; Young Adult | 2015 |
Identification of ofloxacin-resistant Mycobacterium tuberculosis by PCR-RFLP and Sequencing.
Topics: Antitubercular Agents; Codon; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Tuberculosis, Pulmonary | 2016 |
Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China.
Topics: Adolescent; Adult; Aged; Amikacin; Antitubercular Agents; China; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Prospective Studies; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2016 |
Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
Topics: Aminopyridines; Antitubercular Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Gatifloxacin; Gene Expression; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Thailand; Tuberculosis, Pulmonary | 2016 |
Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin.
Topics: Antitubercular Agents; China; DNA Gyrase; Drug Dosage Calculations; Drug Resistance, Bacterial; Fluoroquinolones; Gene Expression; Genotype; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Pulmonary | 2016 |
Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan.
Topics: Adolescent; Adult; Antitubercular Agents; Cross-Sectional Studies; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Pakistan; Prevalence; Retreatment; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2017 |
[The effect of CD4+ CD25+ regulatory T cell inactivation combined with levofloxacin on murine tuberculosis].
Topics: Animals; Anti-Bacterial Agents; Female; Levofloxacin; Mice; Mice, Inbred C57BL; Ofloxacin; T-Lymphocytes, Regulatory; Tuberculosis, Pulmonary | 2009 |
Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Clinical Protocols; Cycloserine; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Iran; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Prothionamide; Treatment Outcome; Tuberculosis, Pulmonary | 2010 |
Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; China; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Mycobacterium tuberculosis; Ofloxacin; Sequence Analysis, DNA; Tuberculosis, Pulmonary; Young Adult | 2010 |
Streptomycin susceptibility and MDR-TB: can we refine the definition of XDR-TB?
Topics: Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Microbial Sensitivity Tests; Ofloxacin; Streptomycin; Tuberculosis, Pulmonary | 2011 |
[Evaluation of tuberculosis treatment including levofloxacin (LVFX) in cases who could not continue standard regimen].
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Tuberculosis; Tuberculosis, Pulmonary | 2011 |
φ(2)GFP10, a high-intensity fluorophage, enables detection and rapid drug susceptibility testing of Mycobacterium tuberculosis directly from sputum samples.
Topics: Antitubercular Agents; Bacteriophages; Genes, Reporter; Genetic Vectors; Green Fluorescent Proteins; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Promoter Regions, Genetic; Recombinant Proteins; Rifampin; Signal-To-Noise Ratio; Sputum; Tuberculosis, Pulmonary | 2012 |
Pulmonary Mycobacterium kyorinense disease showed clinical improvement following combined therapy with clarithromycin and levofloxacin.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Tuberculosis, Pulmonary | 2012 |
Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin.
Topics: Antitubercular Agents; Aza Compounds; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gene Expression Regulation, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Quinolines; Russia; Tuberculosis, Pulmonary | 2013 |
Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.
Topics: Adult; Amikacin; Antitubercular Agents; Capreomycin; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; Humans; Incidence; India; Isoniazid; Male; Mycobacterium tuberculosis; Ofloxacin; Prevalence; Rifampin; Risk Factors; Sputum; Tuberculosis, Pulmonary | 2013 |
Clinical use of Levofloxacin in the long-term treatment of drug resistant tuberculosis.
Topics: Adult; Aged; Anti-Infective Agents; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Mycobacterium; Ofloxacin; Tuberculosis, Female Genital; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
[Sensitivity to levofloxacin of Mycobacterium tuberculosis strains with various phenotype isolated from patients with newly diagnosed and chronic tuberculosis].
Topics: Anti-Infective Agents; Chronic Disease; Drug Resistance, Bacterial; Genotype; Humans; Levofloxacin; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Pulmonary | 2002 |
Superficial fungal infection of the skin during treatment of tuberculosis.
Topics: Anti-Infective Agents; Dermatomycoses; Humans; Male; Middle Aged; Ofloxacin; Tuberculosis, Pulmonary | 2002 |
[A study on the clinical efficacy of a combination regimen with levofloxacin and capreomycin in the treatment of multi-drug resistant pulmonary tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
[A preliminary study on the definition of resistant breakpoints of ofloxacin and levofloxacin for Mycobacterium tuberculosis].
Topics: Adolescent; Adult; Aged; Drug Resistance, Bacterial; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Pulmonary | 2004 |
Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminosalicylic Acid; Antitubercular Agents; Cohort Studies; Cycloserine; Female; Humans; Kanamycin; Korea; Male; Middle Aged; Ofloxacin; Prothionamide; Pyrazinamide; Retrospective Studies; Self Administration; Streptomycin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
Topics: Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Communicable Disease Control; Cycloserine; Directly Observed Therapy; Drug Combinations; Ethionamide; Hong Kong; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Population Surveillance; Program Evaluation; Recurrence; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
Validation of the use of Middlebrook 7H10 agar, BACTEC MGIT 960, and BACTEC 460 12B media for testing the susceptibility of Mycobacterium tuberculosis to levofloxacin.
Topics: Agar; Anti-Bacterial Agents; Bacteriological Techniques; Culture Media; Drug Resistance, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Pulmonary | 2004 |
[Clinical observation on treatment of retreated positive tubercle bacillus pneumoconio-tuberculosis with levofloxacin].
Topics: Aged; Anti-Bacterial Agents; Humans; Levofloxacin; Middle Aged; Ofloxacin; Pneumoconiosis; Tuberculosis, Pulmonary | 2004 |
[A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar].
Topics: Amikacin; Antitubercular Agents; Capreomycin; Chronic Disease; Ciprofloxacin; Cough; DNA, Bacterial; Drug Therapy, Combination; Ethionamide; Humans; Kanamycin; Madagascar; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium bovis; Ofloxacin; Patient Compliance; Polymorphism, Restriction Fragment Length; Sputum; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
Drug-sensitivity profile of clinical Mycobacterium tuberculosis isolates--a retrospective study from a chest-disease institute in India.
Topics: Adult; Aged; Antitubercular Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; India; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Retrospective Studies; Rifampin; Sputum; Treatment Failure; Tuberculosis, Pulmonary | 2005 |
Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs.
Topics: Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Ethionamide; Humans; Kanamycin; Mycobacterium tuberculosis; Ofloxacin; Russia; Tuberculosis, Pulmonary | 2005 |
Rapid detection of ofloxacin resistance in Mycobacterium tuberculosis by two low-cost colorimetric methods: resazurin and nitrate reductase assays.
Topics: Anti-Bacterial Agents; Colorimetry; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Nitrate Reductases; Ofloxacin; Oxazines; Reagent Kits, Diagnostic; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Xanthenes | 2005 |
Case records of the Massachusetts General Hospital. Case 12-2006. A 37-year-old man with hemoptysis and a pulmonary infiltrate.
Topics: Adult; Anti-Infective Agents; Diagnosis, Differential; Hemoptysis; Humans; Lung; Lung Neoplasms; Male; Metronidazole; Mycobacterium tuberculosis; Ofloxacin; Pneumonia; Tomography, X-Ray Computed; Tuberculin Test; Tuberculosis, Pulmonary | 2006 |
Prognostic factors for surgical resection in patients with multidrug-resistant tuberculosis.
Topics: Adult; Aged; Biomarkers; Body Mass Index; Drug Resistance, Multiple, Bacterial; Female; Humans; Lung; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Prognosis; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2006 |
Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Recurrence; Retrospective Studies; Taiwan; Tuberculosis, Pulmonary | 2006 |
Alternative anti-tuberculosis regimen including ofloxacin for the treatment of patients with hepatic injury.
Topics: Antitubercular Agents; Brazil; Cohort Studies; Comorbidity; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Hospitals, Public; Humans; Liver Diseases; Liver Function Tests; Male; Mycobacterium tuberculosis; Odds Ratio; Ofloxacin; Recurrence; Retrospective Studies; Risk Assessment; Severity of Illness Index; Streptomycin; Survival Rate; Treatment Failure; Treatment Outcome; Tuberculosis, Pulmonary; Urban Population | 2007 |
Fluoroquinolones in community-acquired pneumonia when tuberculosis is around: an instructive case.
Topics: Adult; Anti-Bacterial Agents; Community-Acquired Infections; Fluoroquinolones; Humans; Levofloxacin; Male; Mycobacterium tuberculosis; Ofloxacin; Pneumonia, Bacterial; Radiography; Tuberculosis, Pulmonary | 2008 |
[Case of pneumothorax associated with pulmonary Mycobacterium fortuitum infection].
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Combined Modality Therapy; Drainage; Drug Resistance, Bacterial; Humans; Levofloxacin; Male; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Pneumonectomy; Pneumothorax; Recurrence; Treatment Outcome; Tuberculosis, Pulmonary | 2008 |
[Trial of clinical administration of a new antibacterial substance DL 8280 in pulmonary tuberculosis].
Topics: Adult; Anti-Infective Agents; Female; Humans; Male; Middle Aged; Ofloxacin; Oxazines; Tuberculosis, Pulmonary | 1984 |
Long-term treatment of pulmonary tuberculosis with ofloxacin in a subject with liver cirrhosis.
Topics: Administration, Oral; Anti-Infective Agents; Antitubercular Agents; Ethambutol; Follow-Up Studies; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Ofloxacin; Tuberculosis, Pulmonary; Uric Acid | 1995 |
Ofloxacin concentrations in serum, saliva and pleural effusion of patients with pulmonary tuberculosis and lung cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lung Neoplasms; Male; Middle Aged; Ofloxacin; Pleural Effusion; Saliva; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 1995 |
[Ofloxacin-cycloserine-protionamide-INH combination against treatment refractory lung tuberculosis].
Topics: Adult; AIDS-Related Opportunistic Infections; Cycloserine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Ofloxacin; Prothionamide; Recurrence; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1995 |
Long-term safety of ofloxacin and ciprofloxacin in the treatment of mycobacterial infections.
Topics: Antitubercular Agents; Ciprofloxacin; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Ofloxacin; Retrospective Studies; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1995 |
Activity of levofloxacin in a murine model of tuberculosis.
Topics: Animals; Antitubercular Agents; Culture Media; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Levofloxacin; Lung; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Quinolones; Spleen; Stereoisomerism; Tuberculosis, Pulmonary | 1994 |
Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin.
Topics: Adult; Antitubercular Agents; Aspartic Acid; Base Sequence; DNA Gyrase; DNA Primers; DNA Topoisomerases, Type II; DNA, Bacterial; Drug Resistance, Microbial; Female; Histidine; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycobacterium tuberculosis; Ofloxacin; Point Mutation; Polymerase Chain Reaction; Tuberculosis, Pulmonary | 1994 |
Ofloxacin and pulmonary tuberculosis.
Topics: Humans; Ofloxacin; Tuberculosis, Pulmonary | 1994 |
Correlation of serum ofloxacin concentration and serum creatinine level in patients on prolonged therapy.
Topics: Adolescent; Adult; Aged; Chromatography, High Pressure Liquid; Creatinine; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Models, Theoretical; Ofloxacin; Tuberculosis, Pulmonary | 1993 |
Ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin--a south Indian experience.
Topics: Drug Resistance, Microbial; Humans; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Pulmonary | 1993 |
Adverse neurological reactions in patients with multidrug-resistant pulmonary tuberculosis after coadministration of cycloserine and ofloxacin.
Topics: Adult; Cycloserine; Depression; Drug Therapy, Combination; Humans; Male; Middle Aged; Ofloxacin; Seizures; Sleep Initiation and Maintenance Disorders; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1993 |
Resistant tuberculosis: successful treatment with amikacin, ofloxacin, clofazimine, and pas.
Topics: Adult; Amikacin; Aminosalicylic Acid; Antitubercular Agents; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Male; Ofloxacin; Tuberculosis, Pulmonary | 1993 |
Long-term treatment of pulmonary tuberculosis with ofloxacin in a subject with liver cirrhosis.
Topics: Aged; Anti-Infective Agents; Humans; Liver Cirrhosis; Ofloxacin; Tuberculosis, Pulmonary | 1996 |
Pseudomembranous colitis in a patient treated with ofloxacin for tuberculosis.
Topics: Aged; Antitubercular Agents; Enterocolitis, Pseudomembranous; Humans; Male; Ofloxacin; Tuberculosis, Pulmonary | 1996 |
[Use of ofloxacin in infections which do not readily respond to treatment].
Topics: Anti-Infective Agents; Bacterial Infections; Biological Availability; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Ofloxacin; Tuberculosis, Pulmonary | 1996 |
[The combination of amoxicillin-clavulanic acid and ofloxacin in the treatment of multidrug-resistant Mycobacterium tuberculosis].
Topics: Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Clavulanic Acids; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Male; Ofloxacin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
Asymptomatic hepatitis in persons who received alternative preventive therapy with pyrazinamide and ofloxacin.
Topics: Adolescent; Adult; Alanine Transaminase; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Female; Humans; Male; Ofloxacin; Pyrazinamide; Tuberculosis, Pulmonary | 1997 |
[Treatment of patients for chronic pulmonary tuberculosis with expectoration--selection and tolerance to drugs].
Topics: Antitubercular Agents; Chronic Disease; Drug Therapy, Combination; Drug Tolerance; Humans; Incidence; Ofloxacin; Retrospective Studies; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
Fluoroquinolones and tuberculosis.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Ofloxacin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Hea
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Chi-Square Distribution; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Levofloxacin; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pilot Projects; Prospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; United States | 1999 |
Quinolones and multidrug-resistant tuberculosis.
Topics: Anti-Infective Agents; Humans; Ofloxacin; Prevalence; Thailand; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1999 |
[Musculoskeletal clinical adverse effects of ofloxacin].
Topics: Adult; Aged; Anti-Infective Agents; Arthralgia; Arthritis; Humans; Male; Ofloxacin; Tuberculosis, Pulmonary | 1999 |
Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens.
Topics: Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Female; Hong Kong; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Recurrence; Retrospective Studies; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2000 |
Can administration of a fluoroquinolone delay diagnosis of pulmonary tuberculosis?
Topics: Adult; Bronchoalveolar Lavage Fluid; Female; Humans; Mycobacterium tuberculosis; Ofloxacin; Pneumonia; Sputum; Time Factors; Tuberculosis, Pulmonary | 2000 |
Intrapulmonary pharmacokinetics of ofloxacin in drug-resistant tuberculosis.
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Bronchoalveolar Lavage Fluid; Chromatography, High Pressure Liquid; Female; Humans; Lung; Male; Ofloxacin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines.
Topics: Anti-Infective Agents; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Drug Resistance, Multiple; Hospitals; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Philippines; Retrospective Studies; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
The treatment of multidrug-resistant tuberculosis in Turkey.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Logistic Models; Male; Middle Aged; Ofloxacin; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Turkey | 2001 |
Quinolones may mean shorter TB therapy.
Topics: Anti-Infective Agents; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Ofloxacin; Tuberculosis, Pulmonary | 2001 |
Pharmacokinetics of antituberculosis medications delivered via percutaneous gastrojejunostomy tube.
Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Female; Gastrostomy; Humans; Jejunostomy; Levofloxacin; Ofloxacin; Rifampin; Saskatchewan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
[Mycobacterium abscessus infection complicated with diabetes mellitus].
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Diabetes Complications; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Levofloxacin; Male; Mycobacterium Infections, Nontuberculous; Ofloxacin; Tuberculosis, Pulmonary | 2002 |
Ofloxacin population pharmacokinetics in patients with tuberculosis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Female; Humans; Male; Middle Aged; Ofloxacin; Population Surveillance; Tuberculosis, Pulmonary | 2002 |
[Ofloxacin in the treatment of pulmonary changes caused by Mycobacterium avium and Mycobacterium xenopii].
Topics: Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Tuberculosis, Pulmonary | 1992 |
Tolerance of ofloxacin in the treatment of pulmonary tuberculosis in presence of hepatic dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Isoniazid; Liver Function Tests; Male; Middle Aged; Ofloxacin; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1992 |
[Tarivid in the combination therapy of patients with pulmonary tuberculosis].
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Ofloxacin; Tuberculosis, Pulmonary | 1991 |
[Management of INH and RFP-resistant refractory tuberculosis].
Topics: Drug Resistance; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Ofloxacin; Rifamycins; Tuberculosis, Pulmonary | 1991 |
In-vitro activity of ofloxacin against Mycobacterium tuberculosis and its clinical efficacy in multiply resistant pulmonary tuberculosis.
Topics: Adult; Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1990 |
Ofloxacin and imipenem in the treatment of Mycobacterium fortuitum and Mycobacterium chelonae lung infections.
Topics: Adult; Female; Humans; Imipenem; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Ofloxacin; Tuberculosis, Pulmonary | 1990 |
[Rifabutine in the treatment of mycobacterial infections resistant to rifampicin. Preliminary results. Group for the Study and Treatment of Resistant Mycobacterial Infections (GETIM)].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Ofloxacin; Rifabutin; Rifampin; Rifamycins; Tuberculosis, Pulmonary | 1989 |
[Therapeutic effect of Ofloxacin on intractable pulmonary tuberculosis. Chest disease cooperative study unit of National Sanatoriums in Kinki District].
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Japan; Male; Middle Aged; Ofloxacin; Retrospective Studies; Tuberculosis, Pulmonary | 1988 |
[Exacerbation of pulmonary tuberculosis after diagnostic bronchoscopy and its preventive medication].
Topics: Adult; Aged; Bronchoscopy; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Ofloxacin; Retrospective Studies; Tuberculosis, Pulmonary | 1988 |
[Antituberculosis chemotherapy including ofloxacin in patients with pulmonary tuberculosis not treated previously].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Ofloxacin; Oxazines; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1986 |
[Case report on the effectiveness of ofloxacin (Tarivid) in large cavernous lung tuberculosis].
Topics: Drug Therapy, Combination; Female; Humans; Middle Aged; Ofloxacin; Oxazines; Tuberculosis, Pulmonary | 1987 |
[Therapeutic effect of ofloxacin on 'treatment-failure' pulmonary tuberculosis].
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Ofloxacin; Oxazines; Tuberculosis, Pulmonary | 1987 |
[Therapeutic effect of ofloxacin (DL 8280) on pulmonary tuberculosis. (Report of a one year-administration study on sixteen treatment-failure patients)].
Topics: Anti-Bacterial Agents; Drug Evaluation; Humans; Nontuberculous Mycobacteria; Ofloxacin; Oxazines; Tuberculosis, Pulmonary | 1985 |
[Lung infections due to Mycobacterium fortuitum and Mycobacterium chelonae. Reports of nine cases of M. fortuitum infection and four cases of M. chelonae infection].
Topics: Adolescent; Aged; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Oxazines; Tuberculosis, Pulmonary | 1985 |